Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
Clinical trial NCT05583227 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05583227
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2026-07-14
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.